-
The Case for WaitingWith new first-line combination treatments offering deep remissions in multiple myeloma, some people can choose to delay stem cell transplants.
by Sonya Collins
-
Rethinking Brain MetastasesWith the option for targeted treatment and radiation, more people with stage IV cancer are being spared from whole-brain radiation.
by Kendall K. Morgan
-
Facts and Stats
Alcohol’s Link to CancerDeaths from alcohol-related cancers have nearly doubled in recent decades.
by Thomas Celona
-
A Common Sign of Colorectal Cancer That Young Adults Might DismissResearch suggests finding blood in stool is often an indicator of colorectal cancer.
by Kyle Bagenstose
-
Connecting More Patients to Cancer Clinical TrialsAACR conference brings experts together to discuss strategies to reach people historically left out of cancer research.
by Eric Fitzsimmons
-
Treatment Combination Improves Survival in EGFR-positive Lung CancerAdding chemotherapy to targeted therapy improves outcomes for people with advanced EGFR-positive non-small cell lung cancer.
by Sandra Gordon
-
The Enduring Importance of Cancer Disparities ResearchOpening session from AACR conference highlights how perseverance and adversity have informed cancer disparities research over the years.
by Eric Fitzsimmons
-
From the Editor-in-Chief
Reducing Ovarian Cancer RiskResearchers examine whether removing the fallopian tubes could help prevent ovarian cancer.
by William G. Nelson, MD, PhD
-
Forward Look
A Combination Approach for EGFR-positive Lung CancerTwo targeted therapies used together extend survival for advanced non-small cell lung cancer but come with side effects.
by Darcy Lewis
-
Forward Look
A Safer Way to Prevent Blood ClotsA lower-dose blood thinner reduces bleeding risk while still protecting against blood clots.
by Ashley P. Taylor
The ‘Your Friends & Neighbors’ actress explains how her diagnosis challenged many of her assumptions about breast cancer.
by Darlene Dobkowski
Why I Participated in a Clinical TrialWhen doctors told Yvonne McLean Florence she was eligible to participate in a research trial testing an experimental drug, she joined. She wants more people to have the same opportunity.
by Yvonne McLean Florence
Targeted Therapy Improves Pancreatic Cancer SurvivalA recently approved drug that targets RAS proteins meaningfully improves outcomes for people with this difficult-to-treat cancer.
by Sandra Gordon
Bring On the WavesA surfer’s love for the ocean guides her through breast cancer treatment and beyond.
by Cameron Walker
-
AACR OMB Statement and Call to ActionThe AACR is deeply concerned that proposed OMB regulations would disrupt federal research grant giving, severely weakening a program that has supported American medical innovation for decades.
-
AACR Cancer Disparities Progress ReportThe AACR Cancer Disparities Progress Report 2026 highlights recent progress in reducing cancer disparities and emphasizes the continued need for transformative research.
Cancer Research at a Crossroads
